4//SEC Filing
Lang Matthew 4
Accession 0001209191-23-045439
CIK 0001806952other
Filed
Aug 10, 8:00 PM ET
Accepted
Aug 11, 4:24 PM ET
Size
5.4 KB
Accession
0001209191-23-045439
Insider Transaction Report
Form 4
Lang Matthew
Chief Business Officer
Transactions
- Award
Option (right to buy)
2023-08-10+2,250,000→ 2,250,000 totalExercise: $2.31Exp: 2033-08-09→ Common Stock (2,250,000 underlying)
Footnotes (1)
- [F1]1/4 of the option shares shall vest on July 1, 2024, with the remaining option shares to vest in equal monthly installments over the following thirty-six months.
Documents
Issuer
Lyell Immunopharma, Inc.
CIK 0001806952
Entity typeother
Related Parties
1- filerCIK 0001712069
Filing Metadata
- Form type
- 4
- Filed
- Aug 10, 8:00 PM ET
- Accepted
- Aug 11, 4:24 PM ET
- Size
- 5.4 KB